Patent suits are surging in New Jersey courts as drug manufacturers look to enjoin generic versions of their drugs from hitting the market. At least 29 patent suits were filed in the District of New Jersey in November, reflecting a jump from the rate of 18 suits per month in the period from December 2023 to November 2024. Only four patent suits were filed per month in the period from December 2022 to November 2023.